AKT-IN-9
AKT-IN-9 is a potent inhibitor of AKT. Protein kinase B (PKB, also known as AKT) is central to PI3K/AKT/mTOR signaling in cells, and its function is important for cell growth, survival, differentiation and metabolism. AKT-IN-9 has the potential for the research of breast and prostate cancer (extracted from patent WO2021185238A1, compound 1) [1].
Product Specifications
CAS Number
2709045-53-2
UNSPSC
12352005
Target
Akt
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/akt-in-9.html
Solubility
10 mM in DMSO
Smiles
CC(C)NC[C@H](C1=CC=C(C=C1)Cl)C(N2C3CN(C4=C5C(NC=C5)=NC=N4)CC2CC3)=O
Molecular Formula
C24H29ClN6O
Molecular Weight
452.98
References & Citations
[1]Xin Li, et al. Thickened dicyclic derivatives, their preparation methods and their application in medicine. Patent WO2021185238A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Hamster NEDD8-Conjugating Enzyme Ubc12 (UBE2M) ELISA Kit
Hamster NEDD8-Conjugating Enzyme Ubc12 (UBE2M) ELISA Kit
Hamster NEDD8-Conjugating Enzyme Ubc12 (UBE2M) ELISA Kit
Hamster NEDD8-Conjugating Enzyme Ubc12 (UBE2M) ELISA Kit
ADH5 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
